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Excessive synchronization of basal ganglia neural activity at low frequencies is considered a hallmark of Parkinson's disease (PD). However,
few studies have unambiguously linked this activity to movement impairment through direct stimulation of basal ganglia targets at low frequency.
Furthermore, these studies have varied in their methodology and findings, so it remains unclear whether stimulation at any or all frequencies
≤20 Hz impairs movement and if so, whether effects are identical across this broad frequency band. To address these issues, 18 PD patients
chronically implanted with deep brain stimulation (DBS) electrodes in both subthalamic nuclei were stimulated bilaterally at 5, 10 and 20 Hz after
overnight withdrawal of their medication and the effects of the DBS on a finger tapping task were compared to performance without DBS (0 Hz).
Tapping rate decreased at 5 and 20 Hz compared to 0 Hz (by 11.8±4.9%, p=0.022 and 7.4±2.6%, p=0.009, respectively) on those sides with
relatively preserved baseline task performance. Moreover, the coefficient of variation of tap intervals increased at 5 and 10 Hz compared to 0 Hz
(by 70.4±35.8%, p=0.038 and 81.5±48.2%, p=0.043, respectively). These data suggest that the susceptibility of basal ganglia networks to the
effects of excessive synchronization may be elevated across a broad low-frequency band in parkinsonian patients, although the nature of the
consequent motor impairment may depend on the precise frequencies at which synchronization occurs.
© 2007 Elsevier Inc. Open access under CC BY license.Keywords: Synchronization; Basal ganglia; Parkinson's disease; DBSIntroduction
There is extensive evidence that neuronal activity is
abnormally synchronized at low frequencies in Parkinson's
disease (PD) and in animal models of parkinsonism (reviewed in
Gatev et al., 2006; Hammond et al., 2007; Uhlhaas and Singer,
2006). However, this does not, by itself, prove that pathological
synchrony is mechanistically important in parkinsonism. More
persuasive evidence would be the impairment of voluntary⁎ Corresponding author.
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Open access under CC BY license.movement by the artificial synchronization of neural activity
in the basal ganglia. Such synchronization is possible by
stimulating deep brain electrodes implanted for the treatment of
PD at low frequencies, rather than at those frequencies above
100 Hz used for therapeutic benefit. Electrical stimulation of
surgical targets like the subthalamic nucleus (STN) simulta-
neously activates neural elements in the vicinity of the electrode
and this synchronous activity is then propagated onwards, as
evinced by evoked pallidal (Brown et al., 2004; Hashimoto et al.,
2003), cortical (MacKinnon et al., 2005) and muscular activity
(Ashby et al., 1999, 2001).
So far there have been several reports of the impairment of
movement by stimulation of the STN at frequencies ≤20 Hz in
patients with PD. Moro et al. (2002) and Chen et al. (2007)
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respectively, and found this to be slowed. However, Timmer-
mann et al. (2004), using the motor United Parkinson's Disease
rating scale (UPDRS), failed to confirm a worsening during
DBS at 5 and 20 Hz, but did find increased bradykinesia with
stimulation at 10 Hz. Another study evaluated tapping
performance over several frequencies within the same patients,
but only found weak effects that involved relative rather than
absolute impairments in motor performance, superimposed
upon an overall tendency for movement to improve with in-
creasing stimulation frequency (Fogelson et al., 2005).
Accordingly, it is unclear whether stimulation at any or all fre-
quencies≤20Hz impairs movement and if so, whether effects are
identical across this broad frequency band. The issue is an
important one, as although spontaneous synchrony tends to occur
at frequencies centered around 20 Hz in PD (Hammond et al.,
2007), it occurs at rather lower frequencies in the 1-methyl-4-
phenyl-1,2,3,6,-tetrahydropyridine (MPTP) primate model of PD
(Goldberg et al., 2004; Raz et al., 1996, 2000).
Here we contrast the effects of STN stimulation and thereby
extrinsically imposed synchronization at a number of frequen-
cies ≤20 Hz, to establish whether all such frequencies impair
movement and, if so, whether they impair movement in the
same way. To this end we studied performance in a simple
finger tapping task, as this is objective and correlates with motor
impairment (Giovannoni et al., 1999; Rabey et al., 2002), and
considered changes in task execution according to baseline
performance (Chen et al., 2006a).
Materials and methods
Patients and surgery
Twenty patients participated with informed consent and the
permission of the local ethics committees (5 females, mean age
59.5±1.4 years; mean disease duration 13.5±1.0 years). Their
clinical details are summarized in Table 1. Fourteen of these
patients had also been recorded at least 6 months previously in a
different paradigm involving stimulation at 20 Hz, 50 Hz and
130 Hz (Chen et al., 2007). Implantation of bilateral STN DBS
electrodes was performed in all subjects for treatment of
Parkinson's disease at least 6 months prior to study (mean
34.7±5.9 months). The DBS electrode used was model 3389
(Medtronic Neurological Division, Minneapolis, USA) with
four platinum–iridium cylindrical surfaces (1.27 mm diameter
and 1.5 mm length) and a centre-to-centre separation of 2 mm.
Contact 0 was themost caudal and contact 3was the most rostral.
The intended coordinates at the tip of contact 0 were 10–12 mm
from the midline, 0–2mm behind the midcommissural point and
3–5mm below the anterior commissural–posterior commissural
line. Adjustments to the intended coordinates were made in
accordance with the direct visualization of STN in individual
stereotactic MRI (Hariz et al., 2003) and, in the patients operated
in Taiwan (n=7), the results of microelectrode recordings.
Correct placement of the DBS electrodes in the region of the
STN was further supported by: [1] effective intra-operative
macrostimulation; [2] post-operative T2-weighted MRI com-patible with the placement of at least one electrode contact in the
STN region; [3] significant improvement in UPDRSmotor score
during chronic DBS off medication (22.7±3.0) compared to
UPDRS off medication with stimulator switched off (52.6±4.8;
pb0.00001, paired t-test). One patient was excluded due to the
absence of significant improvement in UPDRS motor score
during chronic DBS and another one due tomissing clinical data.
Protocol
All patients were assessed after overnight withdrawal of
antiparkinsonian medication, although the long action of many
of the drugs used to treat PD meant that patients may still have
been partially treated when assessed. They were studied when
the stimulator was switched off and during bilateral STN
stimulation at 5Hz, 10Hz and 20Hz. The stimulation types were
assessed in pseudo-randomized order across patients, as was the
presentation order of trials within a stimulation type. Stimulation
contacts, amplitude and pulse duration were the same as utilized
for therapeutic high frequency stimulation in each subject (see
Table 1). There was no evidence of capsular spread during
stimulation, as determined by clinical examination. Patients
were not informed of the stimulation type. We did not stimulate
one side at a time to avoid possible functional compensation by
the non-stimulated side. We waited 20 min after changing
between conditions before testing. This is sufficient time to elicit
about 75% of DBS effects (Temperli et al., 2003).
Task
The task was repetitive depression of a keyboard key as fast
as possible by rapid alternating flexion and extension of the
index finger at the level of the metacarpophalangeal joint (Chen
et al., 2006a, 2007). Tapping was performed in two runs of 30 s,
separated by ∼30-s rest and each hand tested separately (giving
four runs per condition). Data from one side were rejected as
these were collected contralateral to a previous unilateral
pallidotomy (case 18 in Table 1). The number of taps made
with the index finger in 30 s was recorded and the run from each
pair with the best performance selected for analysis, as this was
less likely to be affected by fatigue, or the effects of impaired
arousal/concentration.
Statistics
The results of the tapping task in patients were analyzed
according to their baseline performance (e.g. without stimula-
tion). The lower limit of normal baseline performance was
obtained by testing ten healthy age matched control subjects (20
sides, 4 males, mean age 57 years, range 52–64 years) using the
same tapping task. The mean tapping rate in this control group
was 162 taps/30 s. The lower limit of the normal range (e.g.
mean− [2×standard deviation]) in this control group was
127 taps per 30 s. The 35 tapping sides studied in the 18
patients were accordingly divided into those with baseline
performance within normal limits (n=17; the mean tapping
performance across this group, 157 taps/30 s, was still lower
Table 1
Clinical details of patients







Medication DBS parameters Pre-op
symptoms
1 50/M 8 11 16/31 L-DOPA 500 mg 1-, 3.0 V 60 μs, 185 Hz Off periods,
5-, 2.5 V 60 μs, 185 Hz FOG
2 59/M 9 24 8/24 L-DOPA 1800 mg/day
Ropinirole 14 mg/day
1-, 3.0 V 60 μs, 130 Hz Off periods,
6-, 2.5 V 60 μs, 130 Hz FOG, LID
Amantadine
100 mg/day
3 58/M 10 22 7/40 L-DOPA 800 mg 1-, 3.6 V 60 μs, 130 Hz Off periods,
Entacapone
400 mg/day
5-, 3.2 V 60 μs, 130 Hz FOG
4 55/M 16 94 18/71 L-DOPA 250 mg 2-, 2.5 V 60 μs, 130 Hz Off periods,
Cabergoline
1.5 mg/day
6-, 2.6 V 60 μs, 130 Hz FOG
5 63/F 10 39 7/36 L-DOPA 750 mg 0-, 3.0 V 60 μs, 130 Hz Off periods,
Ropinirole 9 mg/day 4-, 2.4 V 60 μs, 130 Hz FOG, LID
6 50/F 11 8 37/88 L-DOPA 700 mg 2-, 3.9 V 60 μs, 130 Hz Off periods,
Ropinirole 9 mg/day 5-, 2.9 V 60 μs, 130 Hz FOG, LID
7 59/M 11 25 20/46 L-DOPA 600 mg 0-, 2.8 V 60 μs, 130 Hz Off periods,
Cabergoline 3 mg/day 5-, 3.3 V 60 μs, 130 Hz FOG
8 64/M 19 30 19/39 L-DOPA 250 mg 2-, 3.0 V 60 μs, 130 Hz Off periods,
Pergolide 1 mg/day 5-, 3.3 V 60 μs, 130 Hz FOG
9 68/M 10 10 13/29 L-DOPA 300 mg 1-, 1.8 V 60 μs, 130 Hz Off periods
Ropinirole 9 mg/day 4-, 2.7 V 60 μs, 130 Hz
10 51/F 19 22 12/52 L-DOPA 300 mg 2-, 3.3 V 60 μs, 130 Hz Off periods,
Cabergoline 3 mg/day 5-, 3.0 V 60 μs, 130 Hz FOG
11 65/M 22 12 6/46 L-DOPA 500 mg 1-, 3.0 V 60 μs, 130 Hz Off periods,
Pergolide 3 mg/day 5-, 3.5 V 60 μs, 130 Hz FOG
12 62/F 14 40 35/61 L-DOPA 400 mg 3-, 3.0 V 60 μs, 130 Hz Off periods,
Entacapone
400 mg/day
7-, 3.0 V 60 μs, 130 Hz Tremor, FOG, LID
13 67/M 16 80 38/69 L-DOPA 300 mg L: 2-, 3.3 V 60 μs, 145 Hz Off periods,
Ropinirole
8 mg/day
R: 2-, 3.0 V 60 μs, 130 Hz (Itrel 2) Tremor
14 60/M 13 30 24/46 L-DOPA 200 mg 2-, 3.3 V 60 μs, 130 Hz Off periods,
Pergolide 0.5 mg/day 6-, 3.0 V 60 μs, 130 Hz LID
Amantadine
300 mg/day
15 55/M 10 31 33/44 L-DOPA 1000 mg 2-, 2.6 V 60 μs, 140 Hz Off periods,
Amantadine
100 mg/day
6-, 2.6 V 60 μs, 140 Hz FOG
Biperiden 2 mg/day
16 68/M 15 35 40/70 L-DOPA 450 mg 1-, 2.8 V 60 μs, 130 Hz Off periods,
Amantadine
150 mg/day
6–7+, 3.6 V 60 μs, 130 Hz DIH
17 59/M 10 33 33/57 L-DOPA 750 mg 1-, 3.5 V 60 μs, 140 Hz Off periods,
Entacapone
800 mg/day
5-, 3.5 V 60 μs, 140 Hz Tremor
18 a 58/F 20 78 42/98 L-DOPA 600 mg 1-, 3.2 V 60 μs, 180 Hz Off periods,
Bepireden
150 mg/day
1-, 3.0 V 60 μs, 180 Hz Tremor
Electrode contacts are indicated as convention for Kinetra stimulators (0–3: Left STN; 4–7: Right STN) except for Patient no. 13 (R: Right; L: Left).
a Patient no. 18 was only recorded during Right-hand tapping task due to a previous Right pallidotomy. (FOG: freezing of gait; LID: L-DOPA-induced dyskinesias;
DIH: drug-induced hallucinations.)
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those with baseline tapping rates lower than normal limits
(n=18; mean tapping performance 58 taps/30 s). The rationale
behind this approach was to select those sides (with baseline
performance within normal limits) in which any deleterious
effects of DBS would not be overshadowed by the beneficialeffects of DBS-induced suppression of spontaneous patholog-
ical activity or limited by floor effects due to major baseline
impairment (Chen et al., 2006a, 2007). Four subjects had sides
distributed across the two groups of differing baseline tapping
performance. Tapping rates and coefficients of variation were
normally distributed (one-sample Kolmogorov–Smirnov tests,
Fig. 1. Effects of stimulation frequency on tapping rate off medication. Mean
(±SEM) tapping rate off (‘0 Hz’) and on stimulation at 5, 10 and 20 Hz on those
sides (n=17) with baseline tapping performance within normal range (tapping
off DBS N127 taps in 30 s) (A) and below normal range (n=18) (B). In those
patients with baseline performance within normal limits, tapping rate was
significantly slower during stimulation at 5 and 20 Hz than without stimulation
and there was a similar trend for the 10-Hz stimulation. On those sides with
baseline performance below normal limits no significant differences between the
different stimulation frequencies were found.
Fig. 2. Effects of stimulation frequency on variability of tapping rate off
medication. Mean (±SEM) coefficient of variation (CV) of the intervals between
taps off (‘0 Hz’) and on stimulation at 5, 10 and 20 Hz in patients with baseline
tapping performance within normal range. CVof tap intervals during stimulation
at 5 and 10 Hz significantly increased compared to no stimulation.
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simple contrasts (comparing different frequencies of stimulation
to no stimulation) were performed in SPSS (SPSS for Windows
version 11, SPSS Inc., Chicago, IL, USA). Mauchly's test was
used to determine the sphericity of the data entered in the
ANOVAs, and where data were non-spherical Greenhouse–Geisser corrections applied. Means±standard error of the
means are presented in the text.
Results
Low-frequency stimulation had no reliable clinical effect and
did not consistently induce tremor, mobile dyskinesia, or dystonic
posturing. Four patients experienced dystonic postures during the
experiment and one had increased tremor. However, these effects
were seen for overlapping stimulation frequencies. We divided
the tapping sides into two groups according to whether or not
tapping performance off DBS was within normal limits
established on 20 sides in 10 healthy age-matched subjects (see
Materials and methods). ANOVA of tapping scores with factors
FREQUENCY (four levels: 0, 5, 10 and 20 Hz) and BASELINE
TAPPING PERFORMANCE (two levels: within normal limits
and less than normal limits) demonstrated a within-subjects
interaction between FREQUENCY and BASELINE TAPPING
PERFORMANCE (F[3,48]=4.224, p=0.01). Data were further
analyzed with separate ANOVAs in each baseline tapping
performance group. In those patients with baseline tapping
performance within normal limits, ANOVA with the factor
FREQUENCY confirmed that the latter was a significant main
effect (F[3,48]=3.777, p=0.016). Within-subjects contrasts indi-
cated that tapping during 5 and 20 Hz stimulation was worse than
during no stimulation (F[1,16]=6.385, p=0.022 and F[1,16]=
8.793, p=0.009, respectively). The average deterioration in
tapping rate during 5 and 20 Hz stimulation compared to no
stimulation (0 Hz) in this group was 11.8±4.9% and 7.4±2.6%,
respectively (Fig. 1). There was a trend towards a decreased
tapping performance at 10 Hz compared to 0 Hz (F[1,16]=3.578,
p=0.077). There was no effect of FREQUENCY in patients with
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F[1.9,32.8]=2.202, p=0.128).
We also analyzed the variability in tapping as measured by the
coefficient of variation (CV) of the time intervals between
successive taps on those sides with baseline tapping performance
within normal limits. ANOVA with the factor FREQUENCY
(four levels: 0, 5, 10 and 20 Hz) revealed a significant effect of
FREQUENCY (F[3,48]=3.408, p=0.025). Within-subjects con-
trasts indicated that the CV increased during 5 and 10 Hz
stimulation compared with no stimulation (F[1,16] =5.144,
p=0.038 and F[1,16]=4.852, p=0.043, respectively). The average
increase of the CV during 5 and 10 Hz stimulation compared to
0 Hz in this group was 70.4±35.8% and 81.5±48.2%,
respectively (Fig. 2). There was no difference between the CV
at 20 Hz compared to 0 Hz (F[1,16]=0.871, p=0.365). There was,
however, a trend for the CV with 5 Hz stimulation to exceed that
with 20 Hz stimulation (t-test; p=0.059).
Discussion
We have shown that STN DBS at a variety of low frequencies
can slow distal upper limb movements in PD patients with
relatively preserved baseline tapping function at the time of study.
The effect was present with DBS at 5 Hz and 20 Hz in line with
previous studies (Chen et al., 2007; Fogelson et al., 2005; Moro
et al., 2002), and there was a trend towards a similar effect with
stimulation at 10 Hz (Timmermann et al., 2004). These effects
were apparent when tapping sides were separately analyzed
according towhether the level of baseline performancewaswithin
or outside of normal limits, in line with previous studies
suggesting that deleterious effects of DBS are more evident on
those sides with relatively preserved baseline performance (Chen
et al., 2006a, 2007). The effect was not apparent during
stimulation on those sides with impaired baseline performance,
either because of confounding, albeit mild, suppressive effects of
low-frequency DBS on spontaneous pathological oscillations or
because of floor effects (Chen et al., 2007; Fogelson et al., 2005).
In principle, then, the susceptibility of basal ganglia–cortical
loops to the effects of excessive synchronization may be elevated
across a broad low-frequency band in parkinsonian patients.
Accordingly, the relatively different frequency ranges of patho-
logical synchronization in patients and MPTP-treated primates
(Hammond et al., 2007) may be more indicative of the resonance
properties of basal ganglia networks in the different situations,
rather than any fundamental differences in the mechanism of
bradykinesia. However, it must be stressed that this is a
generalization, and although synchronization at different frequen-
cies may conspire to disturb movement, there may still be subtle
differences in the way movement is impaired. This is brought out
by the differential effects of low-frequency stimulation on the
variation in tapping intervals, evident in differences in the
coefficient of variation and hence independent of any differences
in tapping rate. Only DBS at 5 and 10 Hz increased temporal
variability, whereas DBS at 20 Hz selectively decreased tapping
rates without changing tapping variability.
The implication is that basal ganglia networks are involved
in processing related to the temporal patterning and regularity ofmovement and that these circuits may be particularly suscep-
tible to disruption by pathological synchronization at frequen-
cies ≤10 Hz. In support of basal ganglia involvement in the
temporal patterning of movement, PD patients have increased
temporal variability in finger tapping (Giovannoni et al., 1999;
Shimoyama et al., 1990), and temporal variability in motor
performance is a very early feature of Huntington's disease
(Hinton et al., 2007). Indeed, Flowers considered increased
variability of movement in both time and space to be one of the
core components of motor dysfunction in PD, along with a basic
slowness of movement, and a difficulty in initiating and
maintaining movement (Sheridan et al., 1987). This variability
in motor performance may also relate to the phenomenon of
freezing. No overt freezing episodes were observed during
tapping in our patients, but an increased variability of stride has
been shown in PD patients experiencing freezing of gait
independent of frank freezing episodes (Hausdorff et al., 2003).
However, a primary disturbance of temporal patterning is not
the only potential interpretation for the increased variability seen
during stimulation at 5 Hz and 10Hz. Tremor was not seen during
low-frequency stimulation (except in one patient), in agreement
with Timmermann et al. (2004), nor were there any obvious and
consistent dyskinesias. Nevertheless, it is possible that synchro-
nization at frequencies≤10 Hz induced subtle hyperkinesias that
led to increased temporal variability across taps. A previous case
report describes dyskinetic movements induced by STN DBS at
5 Hz (Liu et al., 2002a), and there is increasing evidence that
excessive synchronization over 4–10 Hz within basal ganglia
circuits may be related to both levodopa-induced dyskinesias in
PD (Alonso-Frech et al., 2006) and mobile elements of dystonia
(Chen et al., 2006b; Liu et al., 2002b; Silberstein et al., 2003).
Relevant in this regard, a recent study demonstrated an increased
variability of speech rate in patients treated with L-DOPA and
suggested that this effect was related to dyskinesia (De Letter
et al., 2006). Variability of swing movement was also observed in
the gait of dyskinetic CP children (Abel et al., 2003).
In summary, our results provide further evidence that DBS of
the STN over a relatively broad band of low frequencies can
impairmovement, in linewith other more circumstantial evidence
of an association between low-frequency synchrony in basal
ganglia–cortical loops and altered movement (see recent reviews
by Gatev et al., 2006; Uhlhaas and Singer, 2006; Hammond et al.,
2007). The present results also raise the important possibility that
the detailed profile of motor abnormalities evident in extrapyra-
midal diseases depends to some extent on the precise frequencies
at which pathological synchronization occurs. Indeed, some
differences in the details of the effects of pathological synchrony
at different frequencies might be anticipated, given the evidence
for selective tuning of basal ganglia–cortical sub-circuits
(Fogelson et al., 2006).
Acknowledgments
This work was supported by research grants from the Medical
Research Council (UK),Wellcome Trust (UK), Fondation pour la
Recherche Medicale (France), Chang GungMemorial University
Hospital (Taipei, Taiwan) and Parkinson Appeal (UK).
130 A. Eusebio et al. / Experimental Neurology 209 (2008) 125–130References
Abel, R., Rupp, R., Sutherland, D., 2003. Quantifying the variability of a
complex motor task specifically studying the gait of dyskinetic CP children.
Gait Posture 17, 50–58.
Alonso-Frech, F., Zamarbide, I., Alegre, M., Rodriguez-Oroz, M.C., Guridi, J.,
Manrique, M., Valencia, M., Artieda, J., Obeso, J.A., 2006. Slow oscillatory
activity and levodopa-induced dyskinesias in Parkinson's disease. Brain
129, 1748–1757.
Ashby, P., Kim, Y.J., Kumar, R., Lang, A.E., Lozano, A.M., 1999.
Neurophysiological effects of stimulation through electrodes in the human
subthalamic nucleus. Brain 122 (Pt 10), 1919–1931.
Ashby, P., Paradiso, G., Saint-Cyr, J.A., Chen, R., Lang, A.E., Lozano, A.M.,
2001. Potentials recorded at the scalp by stimulation near the human
subthalamic nucleus. Clin. Neurophysiol. 112, 431–437.
Brown, P., Mazzone, P., Oliviero, A., Altibrandi, M.G., Pilato, F., Tonali, P.A.,
Di Lazzaro, V., 2004. Effects of stimulation of the subthalamic area
on oscillatory pallidal activity in Parkinson's disease. Exp. Neurol. 188,
480–490.
Chen, C.C., Brucke, C., Kempf, F., Kupsch, A., Lu, C.S., Lee, S.T., Tisch, S.,
Limousin, P., Hariz, M., Brown, P., 2006a. Deep brain stimulation of the
subthalamic nucleus: a two-edged sword. Curr. Biol. 16, R952–R953.
Chen, C.C., Kuhn, A., Trottenberg, T., Kupsch, A., Schneider, G., Brown, P.,
2006b. Neuronal activity in globus pallidus interna can be synchronized to
local field potential activity over 3–12 Hz in patients with dystonia. Exp.
Neurol. 202, 480–486.
Chen, C.C., Litvak, V., Gilbertson, T., Kuhn, A., Lu, C.S., Lee, S.T., Tsai, C.H.,
Tisch, S., Limousin, P., Hariz, M., Brown, P., 2007. Excessive synchroni-
zation of basal ganglia neurons at 20 Hz slows movement in Parkinson's
disease. Exp. Neurol. 205, 214–221.
De Letter, M., Santens, P., De Bodt, M., Boon, P., Van Borsel, J., 2006. Levodopa-
induced alterations in speech rate in advanced Parkinson's disease. Acta
Neurol. Belg. 106, 19–22.
Fogelson, N., Kuhn, A.A., Silberstein, P., Limousin, P.D., Hariz, M.,
Trottenberg, T., Kupsch, A., Brown, P., 2005. Frequency dependent effects of
subthalamic nucleus stimulation inParkinson's disease.Neurosci. Lett. 382, 5–9.
Fogelson, N., Williams, D., Tijssen, M., van Bruggen, G., Speelman, H., Brown,
P., 2006. Different functional loops between cerebral cortex and the
subthalmic area in Parkinson's disease. Cereb. Cortex 16, 64–75.
Gatev, P., Darbin, O., Wichmann, T., 2006. Oscillations in the basal ganglia
under normal conditions and in movement disorders. Mov. Disord. 21,
1566–1577.
Giovannoni, G., van Schalkwyk, J., Fritz, V.U., Lees, A.J., 1999. Bradykinesia
akinesia inco-ordination test (BRAIN TEST): an objective computerised
assessment of upper limb motor function. J. Neurol. Neurosurg. Psychiatry
67, 624–629.
Goldberg, J.A., Rokni, U., Boraud, T., Vaadia, E., Bergman, H., 2004. Spike
synchronization in the cortex/basal-ganglia networks of Parkinsonian
primates reflects global dynamics of the local field potentials. J. Neurosci.
24, 6003–6010.
Hammond, C., Bergman, H., Brown, P., 2007. Pathological synchronization in
Parkinson's disease: networks, models and treatments. Trends Neurosci 30,
357–364.
Hariz, M.I., Krack, P., Melvill, R., Jorgensen, J.V., Hamel, W., Hirabayashi, H.,
Lenders, M., Wesslen, N., Tengvar, M., Yousry, T.A., 2003. A quick and
universal method for stereotactic visualization of the subthalamic nucleusbefore and after implantation of deep brain stimulation electrodes.
Stereotact. Funct. Neurosurg. 80, 96–101.
Hashimoto, T., Elder, C.M., Okun, M.S., Patrick, S.K., Vitek, J.L., 2003.
Stimulation of the subthalamic nucleus changes the firing pattern of pallidal
neurons. J. Neurosci. 23, 1916–1923.
Hausdorff, J.M., Schaafsma, J.D., Balash, Y., Bartels, A.L., Gurevich, T., Giladi,
N., 2003. Impaired regulation of stride variability in Parkinson's disease
subjects with freezing of gait. Exp. Brain Res. 149, 187–194.
Hinton, S.C., Paulsen, J.S., Hoffmann, R.G., Reynolds, N.C., Zimbelman, J.L.,
Rao, S.M., 2007.Motor timing variability increases in preclinical Huntington's
disease patients as estimated onset of motor symptoms approaches. J. Int.
Neuropsychol. Soc. 13, 539–543.
Liu, X., Ford-Dunn, H.L., Hayward, G.N., Nandi, D., Miall, R.C., Aziz, T.Z.,
Stein, J.F., 2002a. The oscillatory activity in the Parkinsonian subthalamic
nucleus investigated using the macro-electrodes for deep brain stimulation.
Clin. Neurophysiol. 113, 1667–1672.
Liu, X., Griffin, I.C., Parkin, S.G., Miall, R.C., Rowe, J.G., Gregory, R.P., Scott,
R.B., Aziz, T.Z., Stein, J.F., 2002b. Involvement of the medial pallidum in
focal myoclonic dystonia: a clinical and neurophysiological case study.
Mov. Disord. 17, 346–353.
MacKinnon, C.D., Webb, R.M., Silberstein, P., Tisch, S., Asselman, P.,
Limousin, P., Rothwell, J.C., 2005. Stimulation through electrodes implanted
near the subthalamic nucleus activates projections to motor areas of
cerebral cortex in patients with Parkinson's disease. Eur. J. Neurosci. 21,
1394–1402.
Moro, E., Esselink, R.J., Xie, J., Hommel, M., Benabid, A.L., Pollak, P., 2002.
The impact on Parkinson's disease of electrical parameter settings in STN
stimulation. Neurology 59, 706–713.
Rabey, J.M., Klein, C., Molochnikov, A., Van Hilten, B., Krauss, P., Bonuccelli,
U., 2002. Comparison of the Unified Parkinson's Disease Rating Scale and
the Short Parkinson's Evaluation Scale in patients with Parkinson's disease
after levodopa loading. Clin. Neuropharmacol. 25, 83–88.
Raz, A., Feingold, A., Zelanskaya, V., Vaadia, E., Bergman, H., 1996. Neuronal
synchronization of tonically active neurons in the striatum of normal and
parkinsonian primates. J. Neurophysiol. 76, 2083–2088.
Raz, A., Vaadia, E., Bergman, H., 2000. Firing patterns and correlations of
spontaneous discharge of pallidal neurons in the normal and the tremulous
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism.
J. Neurosci. 20, 8559–8571.
Sheridan, M.R., Flowers, K.A., Hurrell, J., 1987. Programming and execution of
movement in Parkinson's disease. Brain 110, 1247–1271.
Shimoyama, I., Ninchoji, T., Uemura, K., 1990. The finger-tapping test. A
quantitative analysis. Arch. Neurol. 47, 681–684.
Silberstein, P., Kuhn, A.A., Kupsch, A., Trottenberg, T., Krauss, J.K.,Wohrle, J.C.,
Mazzone, P., Insola, A., Di Lazzaro, V., Oliviero, A., Aziz, T., Brown, P., 2003.
Patterning of globus pallidus local field potentials differs between Parkinson's
disease and dystonia. Brain 126, 2597–2608.
Temperli, P., Ghika, J., Villemure, J.G., Burkhard, P.R., Bogousslavsky, J.,
Vingerhoets, F.J., 2003. How do parkinsonian signs return after discontin-
uation of subthalamic DBS? Neurology 60, 78–81.
Timmermann, L., Wojtecki, L., Gross, J., Lehrke, R., Voges, J., Maarouf, M.,
Treuer, H., Sturm, V., Schnitzler, A., 2004. Ten–Hertz stimulation of
subthalamic nucleus deteriorates motor symptoms in Parkinson's disease.
Mov. Disord. 19, 1328–1333.
Uhlhaas, P.J., Singer, W., 2006. Neural synchrony in brain disorders: relevance
for cognitive dysfunctions and pathophysiology. Neuron 52, 155–168.
